Drug of Abuse Testing Market - Global Forecast 2026-2032

Transformation in the drug of abuse testing market is accelerating as new technologies and regulatory demands reshape service delivery and organizational strategies. Senior stakeholders face a landscape where adapting to innovation, operational risk, and compliance simultaneously is vital for competitiveness.

Market Snapshot: Drug of Abuse Testing Market Overview

The drug of abuse testing market is projected to grow from USD 2.00 billion in 2025 to USD 2.14 billion in 2026, reaching USD 3.34 billion by 2032 at a CAGR of 7.58%. Market momentum is fueled by the uptake of advanced analytical platforms, with demand coming from a wide array of end users such as clinical laboratories, forensic agencies, correctional institutions, and employers. Regional variability, emerging substance trends, and diversification of service lines continue to redefine how providers meet operational and regulatory needs.

Scope & Segmentation of the Drug of Abuse Testing Market

Specimen Matrices: Urine remains the standard matrix, but hair and oral fluid are increasingly adopted for their longer detection windows and reduced vulnerability to tampering, enhancing evidence integrity and collection convenience.
Analytical Platforms: Sophisticated tools—such as LC-MS/MS and LC-QTOF—deliver high-precision screening and confirmation. Immunoassays are still preferred for rapid triage, while both legal and clinical users rely on chromatography-based systems for definitive results.
End-User Segments: Clinical laboratories, forensic setups, hospitals, correctional centers, and workplaces drive the need for panel customization, workflow integration, and compliance with sector-specific protocols.
Panel Design: Providers offer adaptable panels, aligning with prevalent local substance use as well as standardized solutions suitable for scalable organizational adoption.
Regions Covered: The Americas, Europe, Middle East & Africa, and Asia-Pacific each present distinctive regulatory demands, infrastructure maturity, and epidemiological challenges, influencing market strategies and growth potential.

Key Takeaways for Senior Decision-Makers

Ongoing innovation is critical in responding to emerging substances, regulatory developments, and changing testing requirements across diverse sectors.
Modern laboratories prioritize expanding detection ranges and streamlining processes by integrating automation to enhance efficiency in response to new synthetic drug threats.
Diversification of specimen matrices—particularly the rise of hair and oral fluid testing—provides organizations with greater options for improved detection and resistance to sample tampering.
Shifts toward sector consolidation and digital technologies stimulate strategic partnerships, prompting investment in workflow and analytical enhancements.
Providers distinguish their offerings through consultative data analysis, transparency, and the ability to develop multi-matrix panel solutions for complex regulatory environments.
High-growth regions reveal a pattern of rapid technology adoption balanced with intensified regulatory scrutiny and sustained infrastructure development, elevating supply chain and procurement challenges differently across geographies.

Tariff Impact: Navigating Tariffs and Supply Chain Complexity

The introduction of cumulative tariff actions by the United States in 2025 has raised costs for imported testing devices and consumables, compelling organizations to rethink procurement strategies and supply chain management. Laboratories and suppliers now revisit vendor contracts, increase local inventory, and leverage managed service models to mitigate expense fluctuations. Large entities focus on automation and digitalization, while smaller operators consolidate suppliers to stabilize budgets. These adjustments are altering expectations around procurement and shaping sector competitiveness.

Methodology & Data Sources

This analysis draws on a blend of primary interviews with laboratory leaders, in-person site reviews, and regulatory impact studies. Quantitative procurement findings are validated with insights from industry panels, ensuring actionable information tailored to executive decision-making.

Why This Report Matters

Empowers leaders to update analytical services and diversify panel menus while bolstering resilience against supply and regulatory disruptions.
Equips users with in-depth segmentation and regional intelligence for more accurate budgeting and capital allocation.
Supports operational compliance and process efficiency through recommendations tailored to evolving industry standards and risk profiles.

Conclusion

Sustaining market leadership hinges on integrating advanced technologies, expanding specimen testing options, and adapting procurement processes. Proactive investments aligned with evolving patterns will secure long-term sector positioning.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Drug of Abuse Testing Market, by Sample Type

8.1. Hair
8.2. Oral Fluid
8.3. Urine

9. Drug of Abuse Testing Market, by Test Technology

9.1. Chromatography
9.1.1. Gc-Ms
9.1.2. Lc-Ms
9.1.2.1. Lc-Ms/Ms
9.1.2.2. Lc-Qtof
9.2. Immunoassay

10. Drug of Abuse Testing Market, by Drug Panel

10.1. Customized Panel
10.2. Expanded Panel
10.3. Five Panel
10.4. Ten Panel

11. Drug of Abuse Testing Market, by End User

11.1. Clinical Laboratory
11.2. Correctional Facility
11.3. Forensic Laboratory
11.4. Hospital

12. Drug of Abuse Testing Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Drug of Abuse Testing Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Drug of Abuse Testing Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Drug of Abuse Testing Market
16. China Drug of Abuse Testing Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. AccuBioTech Co., Ltd.
17.7. American Bio Medica Corporation
17.8. Bio-Rad Laboratories, Inc.
17.9. Clinical Reference Laboratory, LLC
17.10. Cordant Health Solutions Inc.
17.11. Danaher Corporation
17.12. Drägerwerk AG & Co. KGaA
17.13. Express Diagnostics International Inc.
17.14. F. Hoffmann-La Roche Ltd.
17.15. Laboratory Corporation of America Holdings (LabCorp)
17.16. LGC Group Holdings Ltd.
17.17. LifeLoc Technologies, Inc.
17.18. MP Biomedicals, LLC
17.19. Omega Laboratories, Inc.
17.20. OraSure Technologies, Inc.
17.21. Precision Diagnostics Inc.
17.22. Premier Biotech, Inc.
17.23. Psychemedics Corporation
17.24. Quest Diagnostics Incorporated
17.25. Randox Laboratories Ltd.
17.26. Siemens Healthineers AG
17.27. SureScreen Diagnostics Ltd.
17.28. Thermo Fisher Scientific Inc.
17.29. Wondfo Biotech Co., Ltd.

List of Figures

FIGURE 1. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GC-MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GC-MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GC-MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS/MS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS/MS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-QTOF, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-QTOF, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-QTOF, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CUSTOMIZED PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CUSTOMIZED PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CUSTOMIZED PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY EXPANDED PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY EXPANDED PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY EXPANDED PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICAL LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICAL LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CORRECTIONAL FACILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CORRECTIONAL FACILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CORRECTIONAL FACILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FORENSIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FORENSIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FORENSIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. EUROPE DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. EUROPE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 91. EUROPE DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 93. EUROPE DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 94. EUROPE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 104. AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 105. AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 106. AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 107. AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 108. AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. ASEAN DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. ASEAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 119. ASEAN DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 120. ASEAN DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 122. ASEAN DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 123. ASEAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. GCC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GCC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 126. GCC DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. GCC DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 128. GCC DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 129. GCC DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 130. GCC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. BRICS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. BRICS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 140. BRICS DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. BRICS DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 142. BRICS DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 143. BRICS DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 144. BRICS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. G7 DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. G7 DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. G7 DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. G7 DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 149. G7 DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 150. G7 DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 151. G7 DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. NATO DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. NATO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 154. NATO DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. NATO DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 156. NATO DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 157. NATO DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 158. NATO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 161. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 162. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. CHINA DRUG OF ABUSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 168. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 169. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
TABLE 171. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2032 (USD MILLION)
TABLE 172. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2032 (USD MILLION)
TABLE 173. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Drug of Abuse Testing market report include:

Abbott Laboratories
AccuBioTech Co., Ltd.
American Bio Medica Corporation
Bio-Rad Laboratories, Inc.
Clinical Reference Laboratory, LLC
Cordant Health Solutions Inc.
Danaher Corporation
Drägerwerk AG & Co. KGaA
Express Diagnostics International Inc.
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America Holdings (LabCorp)
LGC Group Holdings Ltd.
LifeLoc Technologies, Inc.
MP Biomedicals, LLC
Omega Laboratories, Inc.
OraSure Technologies, Inc.
Precision Diagnostics Inc.
Premier Biotech, Inc.
Psychemedics Corporation
Quest Diagnostics Incorporated
Randox Laboratories Ltd.
Siemens Healthineers AG
SureScreen Diagnostics Ltd.
Thermo Fisher Scientific Inc.
Wondfo Biotech Co., Ltd.

Table Information

Report Attribute	Details
No. of Pages	186
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.14 Billion
Forecasted Market Value ( USD ) by 2032	$ 3.34 Billion
Compound Annual Growth Rate	7.5%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Drug of Abuse Testing Market Overview

Scope & Segmentation of the Drug of Abuse Testing Market

Key Takeaways for Senior Decision-Makers

Tariff Impact: Navigating Tariffs and Supply Chain Complexity

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Drug Testing Market - Global Forecast 2025-2032

Drugs of Abuse (DOA) Testing Market Report 2025

Drugs of Abuse Testing - Global Strategic Business Report

At-home Drug of Abuse Testing Market - Global Forecast 2025-2032

Drugs of Abuse Testing Market Report: Trends, Forecast and Competitive Analysis to 2031